Eritrea vs Myanmar: Cause of death, by non-communicable diseases, ages 0-4, male
Eritrea
12.7%
in 2021
Myanmar
13.2%
in 2021
Eritrea rank
138th
Myanmar rank
136th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Eritrea
- Myanmar
How they compare
Myanmar currently reports 13.2% against 12.7% in Eritrea, a difference of 0.5%.
Across all 6 years both countries report, Myanmar has been ahead every year.
Eritrea ranks 138th and Myanmar ranks 136th of 185 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.1% | 10.0% | 1.9% | Myanmar |
| 2010s | 11.2% | 13.6% | 2.4% | Myanmar |
| 2020s | 12.6% | 14.4% | 1.9% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Eritrea or Myanmar?
- Myanmar, at 13.2% against 12.7% in Eritrea as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Eritrea and Myanmar?
- 0.5%, with Myanmar ahead.
- How many years of comparable data are there for Eritrea and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and Myanmar rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Eritrea ranks 138th and Myanmar ranks 136th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.